BMC Medicine, 2024
Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank

Wang X., Shi Z., Qiu Y. et al.

Clinical Immunology, 2024
Serum proteomics reveals hemophagocytic lymphohistiocytosis-like phenotype in a subset of patients with multisystem inflammatory syndrome in children

Tulling A., Holierhoek M., Jansen-Hoogendijk A. et al.

PROTEOMICS – Clinical Applications, 2024
Methods and clinical biomarker discovery for targeted proteomics using Olink technology

Wang H., Zhao T., Zeng J. et al.

Frontiers in Immunology, 2024
Plasma proteomics analysis of Chinese HIV-1 infected individuals focusing on the immune and inflammatory factors afford insight into the viral control mechanism

Ni W., Ren L., Liao L. et al.

BMJ Oncology, 2024
First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours

Naing A., Papadopoulos K., Pishvaian M. et al.

Ticks and Tick-borne Diseases, 2024
Diagnostic patterns of serum inflammatory protein markers in children with Lyme neuroborreliosis

Fredriksson T., Brudin L., Henningsson A. et al.

Biomolecules, 2024
GlycA and CRP Are Genetically Correlated: Insight into the Genetic Architecture of Inflammageing

Kasher M., Freidin M., Williams F. et al.

Journal of the European Academy of Dermatology and Venereology, 2024
Exposure–response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis

Soenen R., Schots L., Wang Z. et al.

JCI Insight, 2024
Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humans

Hellgren F., Rosdahl A., Arcoverde Cerveira R. et al.

Heart & Lung, 2024
Causal role of circulating inflammatory cytokines in cardiac diseases, structure and function

Ruan W., Zhou X., Liu H. et al.

Heliyon, 2024
Identification of endophenotypes supporting outcome prediction in hemodialysis patients based on mechanistic markers of statin treatment

Leierer J., Salib M., Evgeniou M. et al.

Brain, Behavior, and Immunity, 2024
Plasma proteomic biomarkers and the association between poor cardiovascular health and incident dementia: The UK Biobank study

Beydoun M., Beydoun H., Hu Y. et al.

Medicine, 2024
Exploring the casual association between gut microbiome, circulating inflammatory cytokines and chronic pancreatitis: A Mendelian randomization analysis

Yang X., Xu H., Liang X. et al.

Cell Reports Medicine, 2024
Metabolic liability for weight gain in early adulthood

Murthy V., Mosley J., Perry A. et al.

International Journal of Molecular Sciences, 2024
Examination of the Complex Molecular Landscape in Obesity and Type 2 Diabetes

Vadadokhau U., Varga I., Káplár M. et al.

Journal of Allergy and Clinical Immunology, 2024
IL-4Rα signaling promotes barrier-altering oncostatin M and IL-6 production in aspirin-exacerbated respiratory disease

Chen C., Buchheit K., Lee P. et al.

American Journal of Respiratory and Critical Care Medicine, 2024
Early Mortality in Clinical Trials of Acute Respiratory Distress Syndrome

Giannakoulis V., Schenck E., Papoutsi E. et al.

AIDS, 2024
Proteomics discovery in children and young adults with HIV identifies fibrosis, inflammatory, and immune biomarkers associated with myocardial impairment

Harrington J., McCrary A., Nguyen M. et al.

JNCI: Journal of the National Cancer Institute, 2024
Prediagnostic plasma proteomics profile for hepatocellular carcinoma

Zhang X., Zhao L., Ngo L. et al.

American Journal of Cancer Research, 2024
Causal relationship between circulating cytokines and follicular lymphoma: a two-sample Mendelian randomization study

Sun C.